Healthcare - Biotechnology - NASDAQ - US
$ 9.84
-1.85 %
$ 833 M
Market Cap
-6.35
P/E
Price Target
Average
128.66%
Revenue Forecast
Estimate
129.90%
EBIT
Estimate
--60.63%
Net Income
Estimate
36.69%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Liquidia Corporation
Wall Street analysts predict an average 1-year price target for LQDA of $22.5 , with forecasts ranging from a low of $17 to a high of $27 .
LQDA Lowest Price Target
Wall Street Target
17 USD
72.76%
LQDA Average Price Target
Wall Street Target
22.5 USD
128.66%
LQDA Highest Price Target
Wall Street Target
27 USD
174.39%
REVENUE FORECAST
Revenue Forecast Chart LQDA
EBIT FORECAST
EBIT Forecast Chart LQDA
NET INCOME FORECAST
Net Income Chart LQDA